Glycopyrrolate
- Product NDC
- 71288-407
- Requested package NDC
- 71288-407-03
- 11-digit product format
- 712880407
- Labeler code
- 71288
- Product ID
- 71288-407_69319d90-2a3e-4514-9959-b75779280e89
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glycopyrrolate
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Meitheal Pharmaceuticals Inc.
- Application
- ANDA211705
- Marketing category
- ANDA
- Marketing start
- 2019-05-15
- Marketing end
- 0000-00-00
- Substance
- GLYCOPYRROLATE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 71288-407 | 71288-407-03 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211705-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2019-03-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211705-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A211705-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2019-03-20 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A211705-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Caplin Steriles Limited | 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | 2025-01-25 | Warnings, Adverse reactions | 211705 ANDA211705 |
| glycopyrrolate | GLYCOPYRROLATE | BE Pharmaceuticals Inc. | d9df3900-a8c2-438b-8971-ba11ff91f90b | 2022-02-24 | Warnings, Adverse reactions | 211705 ANDA211705 |
| Glycopyrrolate | GLYCOPYRROLATE | Somerset Therapeutics, LLC | a46c5ec1-a1b4-46fc-9b37-8da7f0c983d6 | 2022-01-27 | Warnings, Adverse reactions | 211705 ANDA211705 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71288-407-01 | ML - Milliliter | 71288-407 | 4c47a772-d779-4d47-9d19-f726deb5fdbe | 1 | 2019-07-02 |
| 71288-407-02 | ML - Milliliter | 71288-407 | edda245a-7edf-4440-b044-4ba8a025597c | 1 | 2019-07-02 |
| 71288-407-03 | ML - Milliliter | 71288-407 | b7c17347-971c-4828-a67b-167383a23955 | 1 | 2019-07-02 |
| 71288-407-04 | ML - Milliliter | 71288-407 | 2784112e-0136-4112-a2e9-1c104c314f95 | 1 | 2019-07-02 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71288-407-03 | 71288040703 | 25 VIAL, SINGLE-DOSE in 1 CARTON (71288-407-03) > 1 mL in 1 VIAL, SINGLE-DOSE (71288-407-01) | 2019-05-15 | 2023-11-30 | No | No | Current |